Clinical Trials Browser

Neovascularization, Pathologic × Rubidium-82 × 90 days × Clear all

NCT07346404 2026-01-16

RUBIKID

Phase 2 Not yet recruiting

Carcinoma, Renal Cell, Neovascularization, Pathologic